Moqi Liu
Overview
Explore the profile of Moqi Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiao X, Liu M, Li R, Li J, Wang L, Niu G, et al.
Obes Facts
. 2024 Jan;
17(2):131-144.
PMID: 38185107
Introduction: The present study aimed to investigate whether and how normobaric intermittent hypoxic training (IHT) or remote ischemic preconditioning (RIPC) plus normoxic training (RNT) has a synergistic protective effect on...
2.
Liu M, Jiao X, Li R, Li J, Wang L, Wang L, et al.
BMC Med
. 2024 Jan;
22(1):4.
PMID: 38166913
Background: We aimed to determine whether and how the combination of acetazolamide and remote ischemic preconditioning (RIPC) reduced the incidence and severity of acute mountain sickness (AMS). Methods: This is...
3.
Li R, Liu M, Li J, Jiao X, Guo X
Clin Neuroradiol
. 2023 Jun;
33(4):985-992.
PMID: 37284877
Purpose: Accumulating evidence highlights the association of calcium characteristics and cardiovascular events, but its role in cerebrovascular stenosis has not been well studied. We aimed to investigate the contribution of...
4.
Liu M, Yan M, Guo Y, Xie Z, Li R, Li J, et al.
Cells
. 2021 Apr;
10(4).
PMID: 33916503
The detailed characteristics of strokes at high altitudes in diverse nations have not been extensively studied. We retrospectively enrolled 892 cases of first-ever acute ischemic strokes at altitudes of 20,...
5.
Liu L, Zou D, Zhang Y, Zhang Q, Feng Y, Guo Y, et al.
Eur J Pharm Biopharm
. 2020 Jul;
154:62-73.
PMID: 32645384
Base on improving the solubility and permeability of enoxacin (EX) to enhance the antibacterial activity in vitro, three new pharmaceutical salts/cocrystals of EX with oxalic acid (EX·0.5(CHO)·2(HO)), malonic acid ((HEX)·CHO)...